LuxeVista™ADVISORY GROUP

FOCUSED ENGAGEMENT · FIXED FEE

Billing Denial Cleanup

“Claims come back denied or sit unpaid, and nobody owns the follow-up.”

This is one of eleven single-problem engagements. One problem, one deliverable, one number we watch. Priced reasonably for your practice and agreed with you in writing before we start. How fees are set →

The problem
Claims come back denied or sit unpaid.
You get
A denial review, a resubmission routine and a weekly aging check.
We measure
Days to payment and denial rate.

What I look at first

Denials are rarely a billing-software problem. They are a routine problem: who checks eligibility, who codes, who works the aging report on Friday. I review 90 days of denials with your biller, group them by cause, fix the two or three that account for most of the dollars, and set a weekly aging check the owner can see.

What a fix is worth. A 5% denial rate on $40,000 a month of medical billing is $24,000 a year sitting in denials; most of it is recoverable with a routine, not a new biller.Illustration only, using 300 exams a month and a $280 average eyewear sale. Run your own numbers in the Capture Rate Calculator or Value Calculator.

How the engagement runs

Week 1: a 20-minute call, then your reports. Weeks 2–3: I work the problem with you and your team, remote by phone or video, or on site. Week 4: the deliverable above, in writing, with the number we watch and who owns it. Then you run it, with monthly advisory if you want me beside you.

Other problems owners bring me

LuxeVista Advisory Group provides business advisory services only. Results described were achieved in an operating role or in client engagements and depend on each practice’s execution; they are not a guarantee of future results.

Patrick has a strong record of results and building high performance teams. I would characterize Patrick’s leadership mentality with the mantra, “If better is possible, good is not enough.”

Endorsements of my work as an operator and leader, quoted from public LinkedIn recommendations. Read more on the home page.